APA citiranje

Salazar, R., Garcia‐Carbonero, R., Libutti, S. K., Hendifar, A. E., Custodio, A., Guimbaud, R., . . . Yao, J. C. (2017). Phase II Study of BEZ235 versus Everolimus in Patients with Mammalian Target of Rapamycin Inhibitor‐Naïve Advanced Pancreatic Neuroendocrine Tumors. Oncologist.

Citação norma Chicago

Salazar, Ramon, et al. "Phase II Study of BEZ235 Versus Everolimus in Patients With Mammalian Target of Rapamycin Inhibitor‐Naïve Advanced Pancreatic Neuroendocrine Tumors." Oncologist 2017.

MLA citiranje

Salazar, Ramon, et al. "Phase II Study of BEZ235 Versus Everolimus in Patients With Mammalian Target of Rapamycin Inhibitor‐Naïve Advanced Pancreatic Neuroendocrine Tumors." Oncologist 2017.